Tallahassee, FL: The majority of patients registered with the state of Florida to access medical cannabis products report reducing their consumption of prescription opioids, according to data published in the journal Substance Use & Misuse. Investigators affiliated with Florida State University’s College of Medicine assessed health functioning before and after cannabis initiation in a cohort of over 2,100 authorized medical marijuana consumers. Consistent with dozens …
Philadelphia, PA: Older patients with lower back and leg pain due to chronic spinal stenosis experience statistically significant improvements following the use of hemp-derived CBD gel caps, according to data published in the journal Cureus. Researchers affiliated with Thomas Jefferson University in Philadelphia assessed the efficacy of the twice-daily administration of hemp-derived CBD gel caps (15mgs) in a cohort of 48 patients (mean age: 75) with …
Baltimore, MD: Those who consume hemp-derived extracts on a regular basis risk testing positive for cannabis on a urinalysis drug screen, according to data published in the journal Therapeutic Drug Monitoring. A team of researchers from the United States and Canada evaluated whether the ingestion of retail oral hemp-derived CBD products (containing ≤0.3 percent THC) would trigger a positive drug screen for the presence …
CARY, N.C., Oct. 05, 2022 (GLOBE NEWSWIRE) — Relatively unknown until recently, CBD Isolate is among the fastest-growing products in the CBD industry. Joe Kryszak, CEO of Stirling CBD, offers insight about CBD Isolate and why it is red hot. “CBD Isolate is one of the most versatile ingredients in the growing CBD market, mainly due to its powdered form and oil-solubility. This …
Denver, CO: Patients who self-report consuming cannabis following hip or knee surgery are less likely than non-users to engage in the long-term use of prescription opioids, according to data in the journal Arthroplasty Today. A team of investigators affiliated with the University of Denver and with John Hopkins University in Baltimore assessed opioid use trends in a cohort of patients who had recently undergone …
London, United Kingdom: The use of cannabis flowers and extracts is associated with symptom improvements in adults diagnosed with autism spectrum disorder (ASD), according to data published in the journal Therapeutic Advances in Psychopharmacology. British investigators affiliated with Imperial College in London assessed the safety and efficacy of cannabis products in a cohort of autistic adults (mean age: 32) enrolled in the UK Medical Cannabis …
Ontario, Canada: Medical cannabis products are safe and effective for older adults with chronic pain conditions, according to data published in The Journal of Cannabis Research. Researchers assessed the safety and efficacy of cannabis products in a cohort of medically authorized Canadian patients age 65 or older. Subjects in the study used cannabis for at least three months. Consistent with other studies assessing the use of cannabis …
New Haven, CT: Data indicates that CBD is “effective” for improving social anxiety and suggests that it may have “key benefits over existing pharmacotherapies” for social anxiety disorder (SAD), according to a systemic review of human studies published in the journal Psychiatry Research Communications. A pair of researchers affiliated with Yale University reviewed data from seven studies involving 278 total participants. Authors reported: “Overall, …
CARY, N.C., Sept. 28, 2022 (GLOBE NEWSWIRE) — The U.S. market for holistic wellness solutions continues to grow, with CBD and other cannabinoids leading the growth trajectory. According to Joe Kryszak, President of Stirling CBD, he is often asked, “Why does CBD continue to gain acceptance in the marketplace when many other industries are facing a downturn due to reduced consumer …
Tel Aviv, Israel: Children with refractory epilepsy respond favorably to long-term treatment with plant-derived CBD extracts, according to data published in Pediatric Neurology. Israeli researchers assessed the safety and efficacy of artisanal CBD-rich extracts in a cohort of adolescents with treatment-resistant forms of epilepsy. Among patients administered extracts for a period of at least one year, 51 percent experienced a significant decline in seizure …